Ozempic, initially approved for Type 2 diabetes in 2017, has gained popularity as a weight loss drug, Its active ingredient, semaglutide, is also present in Wegovy, a higher-dose version specifically for weight loss
By using high-quality, non-GMO ingredients and advanced liposomal technology, we ensure that you are getting a product that respects your biology
Wyniki bada klinicznych co mwi liczby Faza 2 pierwsze zaskakujce rezultaty W 2023 roku prestiowy New England Journal of Medicine opublikowa wyniki badania fazy 2, w ktrym wzio udzia 338 dorosych osb z BMI powyej 30 (lub 27 z wspistniejcymi chorobami)
Peptides from different categories, such as healing peptides, GH secretagogues, and metabolic peptides, generally combine more safely than multiple peptides within the same category
Obesity increases risk of diabetes, heart disease, fatty liver disease, and early death